This HND piece examines the emerging field of mixed methods research, which strives to combine the best of quantitative and qualitative research approaches. Beginning in the social sciences, over the past few years, it has also moved into the health sciences.
Many researchers in the healthcare field have long appreciated that the highly touted randomized double-blind clinical trial, called a "gold standard" by some, has severe limitations. Indeed, we quote former CDC director Tom Frieden himself on that matter. The piece quotes experts and innovators in this exciting new methodology.
Read the complete article.